p(1),p(5)-di(adenosine-5'-)pentaphosphate has been researched along with suramin in 14 studies
Studies (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Trials (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Recent Studies (post-2010) (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Studies (suramin) | Trials (suramin) | Recent Studies (post-2010) (suramin) |
---|---|---|---|---|---|
215 | 2 | 26 | 3,023 | 92 | 431 |
Protein | Taxonomy | p(1),p(5)-di(adenosine-5'-)pentaphosphate (IC50) | suramin (IC50) |
---|---|---|---|
ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | 3 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 9.76 | |
P2X purinoceptor 2 | Rattus norvegicus (Norway rat) | 4 | |
DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.7 | |
DNA primase | Mycobacterium tuberculosis CDC1551 | 8.2 | |
RmtA | Aspergillus nidulans | 5.9 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 9.4 | |
NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 1.15 | |
NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 1.5667 | |
Protein arginine N-methyltransferase 1 | Homo sapiens (human) | 5.33 | |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (71.43) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miras-Portugal, MT; Pintor, J | 1 |
Assmann, G; Löwe, S; Nofer, JR; Schlüter, H; Tepel, M; Zidek, W | 1 |
Culic, O; Lemmens, R; Teuchy, H; Vanduffel, L | 1 |
Assmann, G; Beinlich, A; Heidenreich, S; Nofer, JR; Schlüter, H; Tepel, M; Walter, M; Zidek, W | 1 |
Bowes, J; Kennedy, C; McIntyre, CA; Obeid, S; Sneddon, P; Westfall, TD | 1 |
Fideu, MD; García-Carmona, F; Gualix, J; Miras-Portugal, MT; Pintor, J; Rotllán, P | 1 |
Asensio, AC; Oaknin, S; Rodríguez-Ferrer, CR; Rotllán, P | 1 |
Bailey, SJ; Hourani, SM; Johnson, CR; Tennant, JP | 1 |
Henning, L; Jankowski, J; Junker, R; Schlüter, H; Tente, IM; Tepel, M; van der Giet, M; Zidek, W | 1 |
Cinkilic, O; Jankowski, J; Schlüter, H; Tepel, M; van der Giet, M; Zidek, W | 1 |
Cunha, RA; Hernández, MD; Miras-Portugal, MT; Pereira, MF; Pintor, J; Ribeiro, JA | 1 |
Arvola, L; Bertelsen, G; Hassaf, D; Ytrehus, K | 1 |
Günthner, T; Jalkanen, S; Jankowski, J; Jankowski, V; Yegutkin, GG; Zidek, W | 1 |
Abramochkin, DV; Kuzmin, VS; Pustovit, KB | 1 |
14 other study(ies) available for p(1),p(5)-di(adenosine-5'-)pentaphosphate and suramin
Article | Year |
---|---|
A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes.
Topics: Adenosine Triphosphate; Animals; Calcium; Dinucleoside Phosphates; Male; Mesencephalon; Presynaptic Terminals; Rats; Rats, Wistar; Second Messenger Systems; Suramin; Synaptosomes; Tetrodotoxin; Time Factors | 1995 |
Diadenosine polyphosphates regulate cytosolic calcium in human fibroblast cells by interaction with P2x purinoceptors coupled to phospholipase C.
Topics: Bridged-Ring Compounds; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytosol; Dinucleoside Phosphates; Fibroblasts; Fura-2; Humans; Manganese; Nickel; Norbornanes; Phosphodiesterase Inhibitors; Purinergic Antagonists; Receptors, Purinergic; Suramin; Theobromine; Thiocarbamates; Thiones; Type C Phospholipases; Vasoconstrictor Agents; Verapamil; Xanthines | 1996 |
Regulation of proliferation of LLC-MK2 cells by nucleosides and nucleotides: the role of ecto-enzymes.
Topics: 5'-Nucleotidase; Acid Anhydride Hydrolases; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Cell Division; Cell Line; Cell Line, Transformed; Dinucleoside Phosphates; Dipyridamole; Enzyme Inhibitors; HeLa Cells; Humans; Levamisole; Nucleoside-Triphosphatase; Nucleosides; Nucleotides; Suramin; Thymidine; Triazines | 1996 |
Diadenosine polyphosphates induce transplasma membrane calcium influx in cultured glomerular mesangial cells.
Topics: Adenosine Triphosphate; Affinity Labels; Angiotensin II; Animals; Calcium; Cell Membrane; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Glomerular Mesangium; Male; Phospholipase D; Rats; Rats, Inbred WKY; Second Messenger Systems; Suramin; Type C Phospholipases; Vasoconstrictor Agents | 1996 |
The interaction of diadenosine polyphosphates with P2x-receptors in the guinea-pig isolated vas deferens.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Analysis of Variance; Animals; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Lethal Dose 50; Male; Muscle Contraction; Norepinephrine; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Receptors, Purinergic P2; Second Messenger Systems; Suramin; Vas Deferens; Vasoconstrictor Agents | 1997 |
Characterization of diadenosine polyphosphate transport into chromaffin granules from adrenal medulla.
Topics: Adrenal Medulla; Animals; Atractyloside; Biological Transport; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Carrier Proteins; Cattle; Chromaffin Granules; Dinucleoside Phosphates; Ethylmaleimide; Kinetics; Models, Biological; Models, Chemical; Nigericin; Substrate Specificity; Suramin; Tritium; Valinomycin | 1997 |
Potent inhibition of specific diadenosine polyphosphate hydrolases by suramin.
Topics: Acid Anhydride Hydrolases; Animals; Brain; Dinucleoside Phosphates; Enzyme Inhibitors; Hydrolysis; Male; Neoplasm Proteins; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Wistar; Suramin; Tissue Extracts | 1998 |
Effects of adenosine 5'-triphosphate, uridine 5'-triphosphate, adenosine 5'-tetraphosphate and diadenosine polyphosphates in guinea-pig taenia caeci and rat colon muscularis mucosae.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Colon; Dinucleoside Phosphates; Guinea Pigs; Male; Rats; Rats, Wistar; Suramin; Uridine Triphosphate | 1998 |
Identification and characterization of P(1), P(7)-Di(adenosine-5')-heptaphosphate from human platelets.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Dinucleoside Phosphates; Humans; Platelet Aggregation; Rats; Suramin; Thrombin; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney.
Topics: Adenosine Triphosphate; Animals; Dinucleoside Phosphates; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Perfusion; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Receptors, Purinergic P2; Renal Artery; Renal Circulation; Suramin; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Diadenosine polyphosphates facilitate the evoked release of acetylcholine from rat hippocampal nerve terminals.
Topics: Acetylcholine; Animals; Dinucleoside Phosphates; Hippocampus; Male; Presynaptic Terminals; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Purinergic P1; Suramin; Synaptosomes; Triazines; Triazoles; Tritium; Xanthines | 2000 |
Positive inotropic and sustained anti-beta-adrenergic effect of diadenosine pentaphosphate in human and guinea pig hearts. Role of dinucleotide receptors and adenosine receptors.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dinucleoside Phosphates; Female; Guinea Pigs; Heart Atria; Humans; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Purinergic Antagonists; Receptors, Purinergic P2; Suramin; Theophylline; Vasoconstrictor Agents | 2004 |
Dinucleotide polyphosphates contribute to purinergic signalling via inhibition of adenylate kinase activity.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylate Kinase; Cells, Cultured; Dinucleoside Phosphates; Humans; Nucleotides; Signal Transduction; Suramin | 2008 |
Diadenosine tetra- and pentaphosphates affect contractility and bioelectrical activity in the rat heart via P2 purinergic receptors.
Topics: Action Potentials; Animals; Dinucleoside Phosphates; Heart; In Vitro Techniques; Male; Myocardial Contraction; Pulmonary Veins; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats, Wistar; Receptors, Purinergic P2; Suramin | 2016 |